Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | $8.6M | $0.02 | -- | -- |
| 07/11/2025 | Q2 | -- | $8.6M | -$0.01 | -- | -- |
| 04/11/2025 | Q1 | -- | $8M | -$0.00 | -- | -- |
| 02/13/2025 | Q4 | -- | $7.3M | -$0.03 | -- | -- |
| 10/24/2024 | Q3 | -- | $6.2M | -$0.00 | -- | -- |
| 07/12/2024 | Q2 | -- | $6.2M | -$0.01 | -- | -- |
| 04/24/2024 | Q1 | -- | $6.4M | -$0.01 | -- | -- |
| 02/15/2024 | Q4 | -- | $6M | $0.01 | -- | -- |
| 10/26/2023 | Q3 | -- | $5.3M | -$0.01 | -- | -- |
| 07/14/2023 | Q2 | -- | $5.9M | -$0.06 | -- | -- |
| 05/04/2023 | Q1 | -- | $5.8M | -$0.00 | -- | -- |
| 02/15/2023 | Q4 | -- | $5.5M | -$0.01 | -- | -- |
| 10/26/2022 | Q3 | -- | $4.7M | $0.01 | -- | -- |
| 07/15/2022 | Q2 | -- | $4.9M | $0.00 | -- | -- |
| 04/28/2022 | Q1 | -- | $5.1M | $0.04 | -- | -- |
| 02/10/2022 | Q4 | -- | $4.6M | $0.01 | -- | -- |
| 10/27/2021 | Q3 | -- | $4.2M | -$0.03 | -- | -- |
| 08/18/2021 | Q2 | -- | $3.8M | $0.04 | -- | -- |
| 03/31/2021 | Q1 | -- | $3.3M | -$0.02 | -- | -- |
| 12/31/2020 | Q4 | -- | $2.2M | -$0.05 | -- | -- |
| 09/30/2020 | Q3 | -- | $1.9M | -$0.02 | -- | -- |
| 06/30/2020 | Q2 | -- | $1.7M | -$0.01 | -- | -- |
| 03/31/2020 | Q1 | -- | $1.6M | $0.00 | -- | -- |
| 12/31/2019 | Q4 | -- | $1.5M | $0.00 | -- | -- |
| 09/30/2019 | Q3 | -- | $1.3M | $0.00 | -- | -- |
| 06/30/2019 | Q2 | -- | $1.3M | $0.00 | -- | -- |
| 03/31/2019 | Q1 | -- | $1.3M | $0.00 | -- | -- |
| 12/31/2018 | Q4 | -- | $1.3M | -$0.00 | -- | -- |
| 09/30/2018 | Q3 | -- | $1M | $0.00 | -- | -- |
| 06/30/2018 | Q2 | -- | $722.2K | -$0.01 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.02 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | $0.12 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | $0.04 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$0.01 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$0.01 | -- | -- |
| 12/31/2016 | Q4 | -- | $3.1M | $0.56 | -- | -- |
| 09/30/2016 | Q3 | -- | $6.3M | $0.04 | -- | -- |
| 06/30/2016 | Q2 | -- | $6.5M | $0.01 | -- | -- |
| 03/31/2016 | Q1 | -- | $6.5M | $0.01 | -- | -- |
| 12/31/2015 | Q4 | -- | $6.4M | -$0.02 | -- | -- |
Carasent AB reported $8.6M worth of top line sales in its most recent quarter.
Carasent AB announced earnings per share of $0.02 which represents a beat of analyst forecast a -- per share.
Carasent AB reported $1.9M that represents $0.03 per share over the last quarter.
Carasent AB's earnings are forecast to grow from -$0.06 per share to -- per share next year representing an increase of --.
Currently, Carasent AB has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 26, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.